JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2014, Vol. 28 ›› Issue (5): 38-41.doi: 10.6040/j.issn.1673-3770.0.2014.189

Previous Articles     Next Articles

Relationship between Treg cells in peripheral blood of patients with allergic rhinitis and special immunotherapy efficacy

YU Yue-jin, TAN Jun, CAO Yun-hong, ZHANG Hui, JIA Xiu-hua, YE Qing   

  1. Department of Otorhinolaryngoloy, Shanghai Seventh People's Hospital, Shanghai 200137, China
  • Received:2014-06-03 Published:2014-10-16

PDF (PC)

533

Abstract: Objective To explore the expression difference of the levels of Treg cells and IL-10 of patients with allergic rhinitis (AR) in serum in different courses of special immunotherapy treatment (SIT) and to explore whether the expressions can forecast the efficacy of SIT. Methods From January 2011, 30 patients with AR were randomly collected and distributed into the 12 months SIT group and the 24 months SIT group. The peripheral blood was taken before and after the SIT, and the expressions of Treg cells were measured by FCM and IL-10 were calculated by ELISA. Results The percentage of Treg cells and the level of IL-10 in the AR groups were significantly decreased compared with those of the control group; After SIT, the percentage of Treg cells and the level of IL-10 in serum were significantly increased than those before SIT. Correlation analysis showed IL-10 was positively related with Treg cells. The clinical efficacy of the 24 months SIT group were higher than that of the 12 months SIT group, and furthermore the percentage of Treg cells and the level of IL-10 in the 24 month SIT group were significantly higher than those in the 12 month SIT group. In effective group, IL-10 level increased significantly after the SIT treatment, while the level of IL-10 did not significantly change after the treatment in non-effective group. Conclusion The percentage of Treg cells in peripheral blood of patients with AR may be useful in predicting the efficacy of the SIT treatment. A 24-month course SIT treatment is better than a 12-month course SIT treatment.

Key words: Allergic rhinitis, Special immunotherapy treatment, T regulatory cell

CLC Number: 

  • R765.21
[1] Bousquet J I, Khaltaev N, Cruz A A,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) [J]. Allergy, 2008, 63 (1):8-160.
[2] El-Qutob D, Mencia G, Fernandez-Caldas E I. Recent advances in immunotherapy for allergic diseases[J]. Recent Pat Inflamm Allergy Drug Discov, 2014, 8(1):24-35.
[3] Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual[J].Immunol Allergy Clin North Am, 2011, 31(3):561-99.
[4] Plewako H, Wosinska K, Arvidsson M, et al. Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy[J]. Int Arch Allergy Immunol, 2006, 141(4):346-353.
[5] James L K, Durham S R. Update on mechanisms of allergen injection immunotherapy[J]. Clin Exp Allergy, 2008, 38(7):1074-1088.
[6] 庞文会,时光刚,时蕾,等.调节性T细胞与IgE、IL-4、IL-5在变应性鼻炎小鼠和鼻用激素抗炎中的实验研究[J]. 山东大学耳鼻喉眼学报,2013,27(2)：29-33. PANG Wenhui, SHI Guanggang, SHI Lei, et al. Experimental study on regulatory T cells and IgE,IL-4 and IL-5 in a mouse model of allergic rhinitis and in administration of nasal corticosteroid [J]. J Otolaryngol Ophthalmol Shandong University, 2013, 27(2)：29-33.
[7] Akidis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between al-lergic-specific T regulatory l and T helper 2 cells[J]. J Exp Med, 2004, 199(11):1567-1575.
[8] Ling E M, Smith T, Nguyen X D,et al. Relation of CD4+CD25+ regulatory T cell suppression of allergen-driven T cell activation to atopic status and expression of allergic disease[J]. Lancet, 2004, 363(9409):608-615.
[9] Xu G, Mou Z, Jiang H, et al. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis[J]. Laryngoscope, 2007,117(5):876-880.
[10] 余少卿,陈英剑,章捷,等.CD4+CD25+调节性T细胞在变应性鼻炎患者外周血淋巴细胞中的含量研究[J].临床耳鼻咽喉头颈外科杂志,2011,25(8):354-355, 359. YUShaoqing,CHENYingjian,ZHANGJie, et al. ContentofCD4＋CD25＋regulatoryTcellsinperipheralblood lymphocytesinpatientswithallergicrhinitis[J]. J Clin Otorhinolaryngol Head Neck Surgery, 2011, 25(8):354-355, 359.
[11] Francis J N, Till S J, Durham S R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy[J]. J Allergy Clin Immunol, 2003, 111(6):1255- 1261.
[12] Francis J N, James L K, Paraskevopoulos G, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity[J]. J Allergy Clin Immunol, 2008, 121(5):1120-1125.
[13] Shevach E M I, DiPaolo R A, Andersson J,et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells [J].Immunol Rev, 2006, 212(1):60-73.
[1] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[2] GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111.
[3] QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[4] DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86.
[5] XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167.
[6] XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33.
[7] HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41.
[8] LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48.
[9] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[10] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[11] LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58.
[12] ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176.
[13] WANG Manxian, ZHENG Quan, YANG Liang. Research progress in the treatment of allergic rhinitis with bacterial lysates [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 141-145.
[14] LIU Chang, FANG Hongyan, LIU Xiao, FU Dongna, WANG He, WANG Jing, YANG Jingpu. Analysis of sensitization characteristics of Artemisia pollen in autumn allergic rhinitis in the Changchun area of China [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 13-19.
[15] ZHANG Jie, CHEN Min, SHEN Zhengzheng, WU Yuhua, LIU Yuanhu, SUN Hao, TAN Xinhua, NI Shuren, YANG Shuxun, SHI Xuezheng, NI Xin. Study on the correlation between allergic rhinitis and coronavirus disease-2019 infection and symptoms in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 36-42.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd